Anti-VEGF therapy and subretinal fibrosis / 眼科新进展
Recent Advances in Ophthalmology
; (6): 583-586, 2017.
Article
en Zh
| WPRIM
| ID: wpr-620112
Biblioteca responsable:
WPRO
ABSTRACT
Subretinal fibrosis contributes to the loss of vision associated with agerelated macular degeneration.Anti-vascular endothelial growth factor therapy is the current standard treatment for exudative age-related macular degeneration.In this review,many risk factors of subretinal fibrosis are discussed,the relationship between anti-vascular endothelial growth factor therapy and subretinal fibrosis,some potential novel therapeutic methods to suppresses subretinal fibrosis are also revealed.
Texto completo:
1
Índice:
WPRIM
Tipo de estudio:
Risk_factors_studies
Idioma:
Zh
Revista:
Recent Advances in Ophthalmology
Año:
2017
Tipo del documento:
Article